Inhibikase Therapeutics
IKT
IKT
11 hedge funds and large institutions have $1.12M invested in Inhibikase Therapeutics in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
11
Holders Change
-1
Holders Change %
-8.33%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$0 |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$5.27K |
| 3 |
3
Renaissance Technologies
New York
|
$25.9K |
| 4 |
MG
4
Mather Group
Chicago,
Illinois
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $814K | 626,500 | +36,925 | +6% |
|
2
William Blair & Company
Chicago,
Illinois
| $164K | 126,120 | +10,000 | +9% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $65.1K | 50,065 | +12,735 | +34% |
|
|
4
Renaissance Technologies
New York
| $25.9K | 19,922 | -900 | -4% |
|
5
Vanguard Group
Malvern,
Pennsylvania
| $21.7K | 16,724 | – | – |
|
6
State Street
Boston,
Massachusetts
| $13.1K | 10,084 | – | – |
|
7
UBS Group
Zurich,
Switzerland
| $6.34K | 4,873 | +4,873 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $5.27K | 4,057 | -1,679 | -29% |
|
9
Morgan Stanley
New York
| $2.17K | 1,667 | – | – |
|
10
Wells Fargo
San Francisco,
California
| $217 | 167 | – | – |
|
11
Bank of America
Charlotte,
North Carolina
| $69 | 53 | +11 | +26% |
|
|
12
Citadel Advisors
Miami,
Florida
| – | – | -37,895 | Closed |
|
|
MG
13
Mather Group
Chicago,
Illinois
| – | – | -334 | Closed |
|
|
CFGS
14
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|